BDNF and early-onset autosomal dominant Alzheimer disease: Indeed, Liu et al. showed that depletion of miR-937 significantly improved the therapeutic outcome in a mouse model for Alzheimer's disease mice, seemingly through augmentation of the levels of BDNF by loss of inhibitory effects of miR-937 [24].